drugset / Trial / NCT03665207

Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients

NCT03665207

RandomizedParallel-groupDouble-blindTreatment

Summary

Critically ill patients usually develop hyperglycemia, which is associated with an increased risk of morbidity and mortality. Controversy exists on whether targeting normal blood glucose concentrations with insulin therapy, referred to as tight blood glucose control (TGC) improves outcome of these patients, as compared to tolerating hyperglycemia. It remains unknown whether TGC, when applied with optimal tools to avoid hypoglycemia, is beneficial in a context of withholding early parenteral nutrition. The TGC-fast study hypothesizes that TGC is beneficial in adult critically ill patients not receiving early parenteral nutrition, as compared to tolerating hyperglycemia.

Timeline

Start
2018-09-18
Primary completion
2022-11-30
Completion
2026-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intravenous

Indications